Newsletter N.11, October 2024

This Project has received funding from the European Union´s Horizon 2020 research and innovation programme under grant agreement No 945118

Evolution of

RESILIENCE

We continue working for the growth of the project because for us every patient counts ❤

Save the Date

Science and Innovation Week

The Madrid Science and Innovation Week is an event for scientific dissemination and citizen participation organized by the Community of Madrid through the Fundación para el Conocimiento Madri+d whose objective is to actively involve society in research and development in science, technology and innovation.
Read More

Important

News

We are pleased to share with you the recently published article on the RESILIENCE design

Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity

Read More

ESC Congress RESILIENCE

Borja Ibáñez, Teresa López and Ricardo Ateggiano, important personalities related to the world of carido-oncology, talk about the importance of identifying cancer patients at high risk of suffering cardiotoxicity.
Read More

Ruber Juan Bravo University Hospital joins the RESILIENCE project


Read More

Infanta Leonor Hospital University joins the RESILIENCE project


Read More

EUROPEAN RESEARCHER'S NIGHT


On September 27th we enjoyed the European Researchers’ Night at the CNIC. 

Attendees were able to approach our project with the renowned cardiologist Andrea Moreno and more members of RESILIENCE.
Read More

I Myostrain Multidisciplinary Conference


RESILIENCE was present at the I Multidisciplinary Myostrain Meeting covering aspects of how to implement new cardiac imaging technologies in research.

Sharing experiences on the RESILIENCE project in London

European Cardiology Congress #London, where expert researchers in the field of cardiac imaging exchanged impressions on their protocol and evolution in the RESILIENCE clinical trial.

Intermittent fasting: how does it influence cardiovascular health?

See you in our social media!

We help you survive cancer with a strong heart ❤

The party responsible for the processing of your personal data is Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) (hereinafter, CNIC), with Fiscal Identification Code (C.I.F.) G-82316753 and domiciled at calle Melchor Fernández Almagro, 3, 28029 Madrid.We inform you that the ownership of the web domain https://resilience-h2020.com/ (hereinafter, the “Website”), belongs to CNIC.The personal data that you provide, either through this Website, through any form/application in paper format or by any other means, will be duly registered and incorporated into CNIC’s data processing systems.Email for information: resilience@cnic.es. Contact details of the Data Protection Officer: dpo@cnic.es

Logotipo Resilience

Are you a patient participating in RESILIENCE? Here you will find useful information about the details of your participation, activities specifically designed for you. You will also be able to contact RESILIENCE researchers.

In accordance with the provisions of Regulation (EU) 2016/679 on the protection of personal data of natural persons (GDPR), the personal information you have provided will be incorporated into the data processing systems of the Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) for the purpose of attending your registration application in the restricted area for patients participating in the RESILIENCE study. The legal basis for processing your personal data for this purpose is your explicit consent. Your personal data will not be disclosed to any recipients other than those to whom you authorise or when required by law to do so. You may exercise your rights of access, right to rectification, to object, to erasure, to restriction of processing, data portability and not to be subject to automated individual decision-making. To exercise these rights, as well as to obtain additional information about the processing of your personal data, you can consult the following link Terms and Conditions